RE:LOOK AT Tobira Therapeutics Inc STOCKS TODAYIt's normal for Tobira, it's a takeover
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Tobira Therapeutics, Inc. to Allergan plc for $28.35 Per Share is Fair to Shareholders -- TBRA
2016-09-20 11:40 ET - News Release
NEW YORK, NY / ACCESSWIRE / September 20, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Tobira Therapeutics, Inc. ("Tobira") (NASDAQ: TBRA) stock prior to September 20, 2016.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Tobira to Allergan plc for $28.35 per share. The deal also includes up to $49.84 per share in Contingent Value Rights, payable upon the successful completion of certain milestones. The deal has a potential approximate value of $1.695 billion. To learn more about the action and your rights, go to: